Synthesis, Characterization and Antimicrobial Activity of Some Synthesized Isoxazole and Pyrazole Derivatives

 

Balaji P. N.*, K. Prathusha, Chandu T. J., M. Sai Sreevani, P. Johnsi Rani and P. Harini,

Department of Pharmaceutical Chemistry, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati. 517503. Andhra Pradesh.

*Corresponding Author E-mail: balajipn47@gmail.com

 

ABSTRACT:

In the development of organic therapeutic agents, pharmaceutical scientists have explored numerous approaches in finding and developing organic compounds that is now available to us in dosage forms for the treat diseases and often for the maintenance of good health. The present work deals with synthesis of some new isoxazole and Pyrazole derivatives which obtained by reaction takes place between the chemicals hydroxyl amine hydrochloride and hydrazine hydrate with synthesized Chalcones (by Claisen-Schmidt condensation) in a refluxing ethanolic medium in alkali condition. The structures for the synthesized compounds are established by FT-IR, 1H NMR and elemental analysis later all compounds were evaluated for antimicrobial activity by zone of inhibition. Significant to moderate results are obtained from the compounds.

 

KEYWORDS: Isoxazole, Pyrazole, Chalcones and antimicrobial activity

 


 

INTRODUCTION:

Chemically the Chalcones are 1,3-diphenyl-2-propene-1-one, in which two aromatic rings are linked by a three carbon with α, β- unsaturated carbonyl system as. This is synthesized by claisen-schmidt condensation of aromatic aldehydes with acetophenone by base catalyzed or acid catalyzed followed by dehydration to yield Chalcones1-4. These Chalcones undergo a variety of chemical reactions and are found useful in synthesis of variety of heterocyclic compounds like isoxazole and pyrazole derivatives they are obtained by reacting Chalcones a starting material with hydroxyl amine hydrochloride and hydrazine hydrate in refluxing alcohol5-7. These synthesized compounds possess a versatile pharmacological activity like antitumor, anticancer, antitubercular, antibacterial, antifungal, antipyretic, antihelmintic, anticonvulsant, anti-inflammatory, analgesic and herbicidal properties. So the obtained compounds are evaluated for antimicrobial activity8,9.

 

MATERIAL AND METHOD:

The chemicals used in this work are taken from SD fine chemicals laboratories Bengaluru, magnetic stirrers are used for starting of the reaction, and the reaction was monitored by TLC using silica gel G60 with ethyl acetate : chloroform of  (6 :4) solvent system and the spots were identified by UV chamber.

 

Melting point of the compounds were determined by open capillary method which are uncorrected, the synthesized compounds are characterized by Elemental analysis, FT-IR and some selected compounds subjected to 1H NMR in CDCl3 solvent, all the compounds are screened for antibacterial and antifungal activity.

 

General procedure for Chalcones:

A mixture of various substituted aromatic aldehydes [0.01 mol] and substituted aryl acetophenone [0.01 mol] was stirred in 30 ml of ethanol at the room temperature in the presence of 10 ml of 15 % KOH was added to the mixture. This mixture was stirred for 16 hr and kept for overnight at room temperature and then it was poured into crushed ice and acidified with dilute acids to neutral. The Chalcones derivatives are precipitates out as solid. Then it was filtered, dried and recrystallized from ethanol.

 

General procedure for synthesis of Isoxazole and Pyrazole derivatives:

A mixture of [0.016 M] of Chalcones with [0.012 M] of Hydroxyl amine hydrochloride was refluxed in 30 ml ethanol with 10 ml of sodium acetate on water bath for 22 hours this for isoxazole. For Pyrazole, the mixture of [0.01M] of Chalcones with [0.01M] of Hydrazine hydrate was refluxed in 30 ml ethanol with 10 ml of KOH on water bath for 24 hours. Then the reacting mixture was cooled and poured into crushed ice, the solid product was precipitate out, then it was filtered, dried and recrystallized from ethanol. The reaction is monitored by TLC. All the compounds are characterized by physical and spectral data as shown in table-1.

 

 

 


Table-1 Physical data for the synthesized compounds BJ (1-8).

Comp. Code

 

R1

 

R2

Mol.

Formula

Mol. Wt

( gms )

%

Yield

M.P.

oc

Calculated % of Elements

C

H

N

O

BJ-1

4-CH3

4-N(CH3)2

C18H18N2O

278

86

188

77.67

6.52

10.06

5.75

BJ-2

4-NH2

4-OH

C15H12N2O2

252

72

192

71.42

4.79

11.10

12.68

BJ-3

4-OCH3

3-NO2

C16H12N2O4

296

76

212

64.86

4.08

9.45

21.60

BJ-4

4-OCH3

4-OH

C16H13NO3

267

82

176

71.90

4.90

5.24

17.96

BJ-5

4-NH2

4-OH

C15H15N3O

253

76

198

71.13

5.97

16.59

6.32

BJ-6

4-NH2

3-NO2

C15H14N4O2

282

66

206

63.82

5.00

19.85

11.34

BJ-7

4-OCH3

4-N(CH3)2

C18H21N3O

295

70

226

73.19

7.17

14.23

5.42

BJ-8

4-CH3

3-NO2

C16H15N3O2

281

68

190

68.31

5.37

14.94

11.38

 

Scheme:-


 

 


Spectral data for the synthesized compounds BJ(1– 8): 10,11.

BJ-1: N,N-dimethyl-4-[3-(4-methylphenyl)-1,2-oxazol-5-yl]aniline,

IR (KBr) cm-1 : 1645 (C=C), 845 (N-O isoxazole), 1475 (C=N isoxazole).

 

BJ-2: 4-[3-(4-aminophenyl)-1,2-oxazol-5-yl]phenol,

IR (KBr) cm-1: 1639 (C=C), 837 (N-O isoxazole), 1438 (C=N isoxazole).

 

BJ-3: 3-(4-methoxyphenyl)-5-(3-nitrophenyl)-1,2-oxazole,

IR (KBr) cm-1: 1633 (C=C), 858 (N-O isoxazole), 1485 (C=N isoxazole).  1H-NMR (CDCl3 δ in ppm) 6.92 (s, 1H, -CH of isoxazole), 3.78 (s, 3H, -OCH3). 8.12-7.58(m, 8H, Ar-H)

 

BJ-4: 4-[3-(4-methoxyphenyl)-1,2-oxazol-5-yl]phenol,

IR (KBr) cm-1: 1633 (C=C), 842 (N-O isoxazole), 1464 (C=N isoxazole). 1H-NMR (CDCl3 δ in ppm) 6.87 (s, 1H, -CH of isoxazole), 3.72 (s, 3H, -OCH3), 8.24-7.82(m, 8H, Ar-H), 11.1(s, 1H, OH).

 

BJ-5: 4-[3-(4-aminophenyl)-4,5-dihydro-1H-pyrazol-5-yl]phenol,

IR (KBr) cm-1: 1622 (C=C), 1610 (C=N pyrazole), 3385 (NH pyrazole). 1H-NMR (CDCl3 δ in ppm) 3.43(d, 2H, CH2 pyrazole), 8.4-7.9(m, 8H, Ar-H), 11.4 (s, 1H, OH).

 

BJ-6: 4-[5-(3-nitrophenyl)-4,5-dihydro-1H-pyrazol-3-yl]aniline,

IR (KBr) cm-1: 1645 (C=C), 1582 (C=N pyrazole), 3412 (NH pyrazole).

 

BJ-7: 4-[3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-5-yl]-N,N-dimethylaniline,

IR (KBr) cm-1: 1658 (C=C), 1568 (C=N pyrazole), 3394 (NH pyrazole). 1H-NMR (CDCl3 δ in ppm) 3.22(d, 2H, CH2 pyrazole), 8.1-7.4(m, 8H, Ar-H), 3.9(s, 3H, OCH3).

 

BJ-8: 3-(4-methylphenyl)-5-(3-nitrophenyl)-4,5-dihydro-1H-pyrazole,

IR (KBr) cm-1: 1668 (C=C), 1597 (C=N pyrazole), 3465 (NH pyrazole).

              

Biological activity 8,9:

All synthesized compounds were screened for antibacterial and antifungal activity by cup plate method from the standard procedure; the two concentrations are taken i.e. 50 & 100 µg/ml over a different bacterial strains and fungal strains as shown in table. The values obtained is compared with the values produced from the standard drugs like Procaine penicillin, Streptomycin for bacterial and Griseofulvin for Fungal and the dimethyl form amide (DMF) was used as control for both the strains. Some of the compounds show significant property compared with the standard and other shows moderate. This will be shown in the table-2.


Table-2 Anti-Microbial activity of the synthesized compounds:

Comp

code.

Mean zone of inhibition in ( mm )

Streptococci

( G + ve )

Pseudomonas

aeruginisa ( G - ve )

Staphylococcus aureus ( G + ve )

E. coli ( G - ve )

Candida albicans

Aspergillus flavus

50 µg

100µg

50µg

100µg

50 µg

100µg

50µg

100µg

50µg

100µg

50 µg

100µg

BJ-1

13

18

16

18

17

19

14

18

14

17

17

19

BJ-2

18

19

14

16

18

21

17

20

16

19

14

17

BJ-3

17

21

17

20

13

20

18

20

17

19

14

16

BJ-4

14

16

15

20

14

18

17

19

16

18

18

19

BJ-5

15

18

14

16

13

18

15

17

15

18

11

17

BJ-6

17

20

17

18

19

21

16

20

17

18

13

16

BJ-7

16

18

15

17

17

19

16

19

18

20

15

17

BJ-8

18

20

16

19

18

20

16

20

18

19

18

20

Procaine penicillin

19

22

-

-

21

24

-

-

-

-

-

-

Streptomycin

-

-

18

22

-

-

19

22

-

-

-

-

Griseofulvin

-

-

-

-

 

-

-

-

19

24

18

22

 


RESULTS AND DISCUSSIONS:

From the obtained results, it is evident that most of the compounds like BJ- 2, 3, 6 and 8 show a significant activity against bacterial strains like Streptococci, Staphylococcus aureus, Pseudomonas aeruginisa and Escherichia coli. And the compounds like BJ - 1,3,4,7 and 8 shows a significant activity against fungi like Candida albicans and Aspergillus flavus and remaining compounds showed moderate activity against all bacteria and fungi tested.

 

CONCLUSION:

The prepared new series of Isoxazole and Pyrazole derivatives are identified by spectral data’s and form the Antimicrobial activity report  the compounds shows significant to moderate properties and they also poses a wide variety of biological activities as mentioned in literature.

 

ACKNOWLEDGMENT:

The author and co-workers thankful to Principal Dr. D. Ranganayakulu, Department of Pharmacology and the Management and Chairperson Smt. P. Sulochanadevi, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati for providing facilities to successfully completing this project. Prof. Dr. B. H. M. Jayakumar Swamy, Dept. of Pharma. Chemistry, SCS College of Pharmacy, Harapanahalli for their help in spectral analysis and Biological activity so on.

 

REFERENCE:

1.       Chetana B. Patil, S. K. Mahajan, Suvarna A. Katti. Chalcone: A Versatile Molecule. J. Pharm. Sci. & Res. Vol.1(3), 2009, 11-22.

2.       R. Kalirajan, S.U.Sivakumar, S. Jubie, B. Gowramma and B. Suresh.  Synthesis and Biological evaluation of some heterocyclic derivatives of Chalcones. International Journal of ChemTech Research, Vol.1,No.1, pp 27-34, Jan – March 2009.

3.       P.M. Gurubasavaraja Swamy  and Y.S. Agasimundin. Synthesis and Antimicrobial Activity of Some Novel Chalcones Containing 3-Hydroxy Benzofuran.  Acta Pharmaceutica Sciencia 50:197-202.

4.       Budak, Yakup, Ceylan, Mustafa. Synthesis and Characterization of α-Bromo Chalcone Derivatives. Chinese Journal of Chemistry, 2009, 27, 1575—1581.

5.       Ausra Voskiene, Vytautas Mickevicius, and Gema Mikulskieneb. Synthesis and structural characterization of products condensation 4-carboxy-1-(4-styrylcarbonylphenyl)-2-pyrrolidinones with hydrazines. Arkivoc 2007 (xv) 303-314.

6.       V.V. Kachhadia, M.R. Patel, and H.S. Joshi. Synthesis of Isoxazoles and Cyanopyridines Bearing Benzo(b)thiophene Nucleus as Potential Antitubercular and Antimicrobial Agents. Journal of Sciences, Islamic Republic of Iran 15(1): 47-51 (2004).

7.       Jayanti Rajora and Y.K. Srivastava. Synthesis and antimicrobial activities of some benzimidazolyl pyrazoles.  Rasayan j.chem, Vol.2, No.3 (2009), 655-658.

8.       Anjani Solankee and Yogesh Prajapati. An efficient synthesis of some new fluorine containing acetyl pyrazoline and isoxazole derivatives and their antibacterial activity.

9.       S.S.Panda and P.V.R. Chowdary. Synthesis of novel Indolyl-pyrimidine Anti-inflammatory, Antioxidant and Antibacterial Agents. Indian journal of Pharmaceutical Sciences, March April 2008.

10.     Scoog, Lorley. Principles of instrumental analysis, IVth edition. Wilson book distributers, Mumbai Cambridge; 1971.

11.     William kemp. Infrared spectroscopy, Organic spectroscopy. ELBS with Mc Millain 3rd ed. 1991;19-96.

12.     Indian Pharmacopoeia controller of publications, Delhi, India. Vol II. A-9.1, 1996:100.

 


 

 


 

 

Received on 20.10.2010        Modified on 02.11.2010

Accepted on 12.11.2010        © AJRC All right reserved

Asian J. Research Chem. 4(2): February 2011; Page 301-303